Study title: A single-centre, non-blinded, randomised, parallel comparison of the efficacy and safety of intravenous versus rapid subcutaneous infusion of immunoglobulin in paediatric patients with Primary Immunodeficiency Disease
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Immune System Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: IMMUNOGLOBULINS | |||||
ATC code: | |||||
Document link: 02 IG704 (synopsis).pdf | |||||
Document date: 2011-11-10 | |||||
Study number: IG704 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |